IMPORTANCE Parathyroid biopsy represents a means for normal and hyperfunctional glands to be distinguished intraoperatively. However, no data exist to guide surgeons regarding how much of a parathyroid gland must be biopsied to satisfy the 20% rule.
P rimary hyperparathyroidism (PHPT) is a common endocrine disorder with approximately 100 000 new cases diagnosed each year in the United States. 1, 2 Primary hyperparathyroidism is caused by excessive secretion of parathyroid hormone (PTH) by single or double adenomas, multigland hyperplasia, or rarely, parathyroid carcinoma. 1, 3 Regardless of the disease etiology, complete surgical removal of the hyperfunctional parathyroid tissue is the only hope for cure. 2 This traditionally involves bilateral neck exploration (BNE), inspection of all 4 parathyroid glands, and removal of any grossly enlarged lesions. 4, 5 However, over the past 2 decades there has been a growing trend toward more focused and less invasive techniques. 3, [5] [6] [7] [8] Focused parathyroidectomy relies on highly sensitive and specific preoperative imaging localization that suggests where the dissection should begin and potentially eliminates unnecessary BNE and dissection of multiple glands. [8] [9] [10] After removal of the target lesion(s), intraoperative cure is confirmed by measuring intraoperative parathyroid hormone (IOPTH) changes and/or using radioguided techniques. [11] [12] [13] A greater than 50% drop from the patient's baseline IOPTH level, and into the normal range, within 10 to 15 minutes after resection of the target gland is indicative of biochemical cure. [14] [15] [16] If IOPTH levels fail to drop adequately, further exploration for hyperfunctional parathyroid tissue is generally indicated. Thus, the IOPTH assay enables the surgeon to functionally evaluate all parathyroid glands. 17 Potential disadvantages associated with measuring IOPTH include assay and operating room costs, inaccessibility to the technology, prolonged operative times, and the potential for false-positive and falsenegative results. 12, 18, 19 Some surgeons use the gamma probe as an adjunct to or in place of IOPTH measurement to confirm the correct and total excision of abnormal parathyroid tissue. Following preoperative 99m Tc-sestamibi injection, intraoperative cure is indicated by gamma probe readings showing that the resected gland emits radioactive counts greater than 20% of background. 11, 20, 21 The usefulness of this criteria, which is known as the Norman 20% rule, has also been demonstrated for hyperplastic glands. 22 Importantly, the only way to definitively rule out other hyperfunctional parathyroid tissue with the gamma probe is to individually evaluate the radioactivity of each gland ex vivo. This is accomplished by measuring the contained radioactivity of each gland after removal of adenomas and hyperplastic glands or via biopsy of all other glands that are not obviously enlarged and can be left in situ. 23 To avoid excising normal parathyroid tissue, those glands that appear slightly enlarged or suspicious can be cut in half to measure their physiologic activity. If the biopsy specimen contains less than 20% of background radiation, the gland is considered normal and the remainder of the gland is left alone. Accordingly, multigland disease is never missed and normal glands are always preserved, although normal parathyroid gland mass is essentially reduced by 25 to 50%. 20 The major disadvantage associated with this technique is that normal glands are routinely manipulated, which may increase the risk of developing parathyroid ischemia and/or fibrosis resulting in immediate or delayed hypoparathyroidism. 24, 25 While parathyroid gland weight and size have been intensively examined for their relationship to ex vivo parathyroid counts, no studies have quantified the minimal proportion of individual parathyroid glands that must be biopsied to make a reliable intraoperative radioguided determination of normal vs hyperfunctional tissue. This is especially important when the gamma probe is used as the sole determinant of parathyroid function and serves as the deciding factor for whether a parathyroid gland is removed or left in situ. Thus, the purpose of this study is to quantify the proportion of a parathyroid gland that must be biopsied to reliably assess for the 20% rule.
Methods
The University of Arkansas for Medical Sciences institutional review board approved the study protocol and written informed consent was waived owing to the retrospective nature of the data used. Between May and October 2015, 24 patients (16 women; mean [SD] age 66.6 [10] years; range 51-83 years) with PHPT were included. Patients with secondary HPT, familial HPT, or those undergoing revision thyroid/ parathyroid surgery were excluded. All procedures were performed in an outpatient setting at a tertiary care facility. An adenoma was defined as hypercellularity in 2 or fewer glands in the presence of 1 or more normal-appearing glands. Hyperplasia was defined as hypercellularity in 3 or more excised glands from the same patient. All parathyroid specimens were submitted for permanent histopathologic analysis.
Patients were injected with 99m
Tc-labeled sestamibi (18.4-30.0 mCi) 1 to 5 hours prior to starting the procedure. A 2.5 to 3.0 cm midline incision in the lower neck was used in all cases, and no incisions were extended if the patient required conversion to a BNE. Patient IOPTH levels were measured preoperatively and at 2 different time points (10 minutes and 20 minutes) following excision of the final diseased gland. At our institution, we use a drop in IOPTH levels of 50% AND into the normal PTH range (12-88 pg/mL) to confirm removal of all hyperfunctional parathyroid tissue before concluding the procedure.
Key Points
Question What proportion of a hyperfunctional parathyroid gland must be evaluated with the gamma probe to satisfy the Norman 20% rule?
Findings In this case series parathyroid biopsies satisfied the 20% rule with an accuracy that varied significantly with the relative proportion of the parent gland represented: half or more (96.6%), a quarter to one half (87.0%), less than a quarter (63.6%).
Meaning Parathyroid biopsies accounting for less than half of a parathyroid gland are not sensitive enough to reliably rule out a hyperfunctional parathyroid gland. Manipulation and excision of half of 1 or more parathyroid glands for ex vivo counts may increase the patient's risk for developing hypoparathyroidism.
Relative radioactivity was defined as ex vivo radioactivity divided by the radioactivity over a neutral zone (background measured over the right shoulder). Subcutaneous fat was used as an internal negative control. Immediately after extirpation, intact glands were sectioned according to 1 of 3 randomly assigned protocols: (1) divided into halves serially along the longitudinal axis, until only 1 to 2 mm of tissue remained; (2) pie-shaped sections (1-2 mm) originating from the center of the intact gland; (3) parallel sections (1-2 mm) across the intact gland ( Figure 1) .
A handheld gamma probe (neo2000 GDS, Neoprobe Corp; 14 mm probe, spatial resolution 15 mm, angular resolution 25°) was used to evaluate intact glands, individual biopsy sections, and various combinations of adjacent biopsy sections ex vivo. The tissues were placed on the tip of the inverted gamma probe in approximately the same position for each count. To avoid potential background interference from the patient, measurements were obtained remotely. For each biopsy (including combinations of adjacent biopsies), absolute weight (mg), relative weight compared with the intact parent gland (%), absolute emitted gamma radiation (counts per second [cps]), relative emitted radiation compared with parent gland (%), and emitted radiation compared to background (%) were obtained.
Statistical Analysis
We used SAS statistical software (version 9.2, SAS Institute Inc) and R statistical software (version 2.9.2, R Foundation) for statistical analysis. Radioactivity (cps) was expressed as the mean (SD). Relative radioactivity was calculated as a function of ex vivo radioactivity over background radioactivity and expressed as a percentage. For statistical analysis, categorical data were analyzed using the 2-sided Fisher exact test. Group data with a normal distribution were compared using student t test or analysis of variance; nonparametric data were compared with the Mann-Whitney U test. Regression analyses were used to define correlation (Pearson method) between variables. Results were deemed to be statistically significant if P<.05, and 95% confidence intervals (CIs) were provided to measure the precise effect size in all cases.
Results
Thirty-three glands from 24 patients were evaluated. A BNE was performed in 7 of 24 (29.2%) cases. Concurrent thyroid nodules were present in 10 of 24 (41.7%) patients. No complications were encountered during any of the procedures. Mean (SD) time from injection to intraoperative evaluation of contained radioactivity was 154 (54) minutes (interquartile range, 64 minutes). The locations of the 33 hyperfunctional parathyroid glands were right superior (n = 8), right inferior (n = 7), left superior (n = 10), left inferior (n = 4), and ectopic (n = 4).
Mean (SD) baseline calcium and PTH levels were 10.5 (0.5) mg/dL (range, 9.3-11.3 mg/dL) and 199.3 (372.5) pg/mL (range, 66.1-1940.8 pg/mL), respectively. Following excision of the diseased lesion, IOPTH levels were 76.5 (64.5) (range 18.0-335.0) at 10 minutes and 64.1 (71.2) pg/mL (range, 8.0-263.0 pg/mL) at 20 minutes. Postoperative calcium and PTH levels were 9.6 (0.7) mg/dL (range, 8.3-11.5 mg/dL) and 65.8 (41.2) pg/mL (range, 6.7 to 188.7 pg/mL), respectively. Mean (SD) vitamin D levels (normal >30 ng/mL) were 32.3 (18.0) ng/mL (range, 11.8-74.3 ng/mL). Median (SD) creatinine levels were 0.9 (1.9) mg/dL (range, 0.6 to 10.0).
On gross observation, 29 glands (87.9%) were ovoid and 4 glands (12.1%) were elongated. Histopathologic analysis demonstrated hypercellularity in 32 glands and normocellularity in 1 (clinically enlarged but nonhyperfunctional). One parathyroid gland, which did not exceed 20% of background radioactivity, was hypercellular but possessed a large fibrous band (atypical adenoma). One ovoid gland had a high prevalence of calcifications, and 1 elongated adenoma was partially cystic. Both of these glands exceeded 20% of background radioactivity ex vivo. Of note, 1 patient with a solitary adenoma (preoperative Ca 10.1 mg/dL; PTH 134.1) had a falsenegative gamma probe reading (14.5% over background) but IOPTH levels dropped by over 50% and into the normal range 20 minutes after excision (25 pg/mL); permanent histopathologic analysis demonstrated a hypercellular gland and follow-up laboratory tests demonstrated biochemically resolved disease.
In total, 253 biopsy samples were obtained from 33 parathyroid glands (solitary adenoma, 18; double adenoma, 10; hyperplasia, 4; normal, 1). Mean (SD) background radioactivity (right shoulder) was 2552 (992) cps (range, 1200-5500 cps). Mean (SD) ex vivo subcutaneous fat radioactivity was 70 (27) cps (range, 35-150 cps); subcutaneous fat never approached 20% of background (2.9% [1%]; range 1.6%-8.0%). The mean (SD) weight and size of the hyperfunctional glands were 607 (583) mg (range, 77 mg to 2420 mg) and 1.7 (0.6) cm (range, 0.5 cm to 3.3 cm), respectively. When evaluating intact glands, absolute ex vivo counts correlated with both gland weight (Pearson coefficient, 0.45; 95% CI, 0.11-0.68) and gland size (Pearson coefficient, 0.54; 95% CI, 0.23-0.74).
When evaluating biopsies of hyperfunctional parathyroid glands, absolute ex vivo radioactivity correlated with biopsy weight (Pearson coefficient, 0.53; 95% CI, 0.43-0.61). Parathyroid biopsies satisfied the 20% rule with an accuracy that depended on the relative proportion of the parent gland rep- Immediately after extirpation, intact glands were sectioned according to 1 of 3 randomly assigned protocols. A, Divided into halves serially along the longitudinal axis, until only 1 to 2 mm of tissue remained; B, pie-shaped sections (1-2 mm) originating from the center of the intact gland; C, parallel sections (1-2 mm) across the intact gland. Figure 2) . When comparing 39 pie-shaped and 86 parallel/vertical biopsies of equal weight, there were no significant differences in satisfaction of the 20% rule between biopsy techniques if at least a quarter of the gland was represented in the biopsy (94.9% vs 88.4%; absolute difference, 6.5%; 95% CI, −3.0% to 16.0%). However, when less than a quarter of the gland was removed, pie-shaped biopsies were more likely to satisfy the 20% rule compared with parallel biopsies of the same weight (78.4% vs 56.2%; absolute difference, 22.2%; 95% CI, 4.7%-39.7%).
Parathyroid Gland Biopsy Excision Technique and Ex Vivo Radiation Counts
When controlled for weight, we did not identify any differences between biopsies obtained from single adenomas 
Discussion
In the present study, parathyroid biopsies satisfied the 20% rule with an accuracy that depended on the relative proportion of the parent gland represented. We found that the 20% rule cannot reliably rule out the presence of a hyperfunctional parathyroid lesion unless half of a parathyroid gland is biopsied during radioguided parathyroidectomy. There were no differences between biopsy samples obtained from single adenomas vs double adenomas when comparing radioactivity (normalized to background) per mg of parathyroid tissue. In contrast, adenomas contained considerably higher radioactivity per mg of tissue compared with hyperplastic and normal glands. When less than a quarter of the gland was represented, pie-shaped biopsies were more likely to exceed 20% of background radiation compared with parallel/ vertical biopsies of the same weight.
In 1999, Murphy and Norman 11 reported that the amount of contained radioactivity within a parathyroid gland may be used as an instantaneous measure of its physiologic activity. They found that lymph nodes, fat, and normal glands never contained more than 2.2% of background radioactivity, whereas thyroid and hyperplastic glands never contained more than 16%. Radioactivity of adenomas, in contrast, exceeded background by an average of 60% (range, 18%-136%). The conclusion, now known as the 20% rule, is that only a parathyroid adenoma will contain more than 20% of background. Others have similarly found that contained radioactivity often correlates with other parathyroid pathologic abnormalities. Chen and colleagues 22 observed that single adenomas had higher ex vivo counts than double or triple adenomas, which in turn had higher ex vivo counts than hyperplastic glands. Importantly, this same study demonstrated significant overlap in the range of counts among these groups. In particular, adenomas and hyperplastic glands both registered ex vivo counts well over 20% of background. Thus, while ex vivo counts may be specific enough to distinguish hyperfunctional lesions from normal glands or nonparathyroid tissue, there is little evidence to suggest the counts are specific enough to classify the etiology of parathyroid disease (eg, adenoma vs hyperplasia). 26 Norman and Politz 12, 20 found that neither size nor weight of parathyroid adenomas could be used to predict contained Biopsy specimens representing at least half of the parent hyperfunctional parathyroid gland satisfied the 20% rule in 96.6% of cases (56 of 58); in contrast, when less than 10% of the parent gland was biopsied, the 20% rule was only satisfied in 48.3% of cases (14 of 29) (absolute difference, 48.3%; 95% CI, 29.5%-67.1%). The dotted line represents the cutoff for the 20% rule. Six biopsies with ex vivo counts greater than 250% compared with background are not illustrated for visualization purposes. radioactivity (r = 0.77). They reasoned that, while larger tumors generally accumulate more sestamibi and emit higher ex vivo counts compared with smaller tumors, there are notable exceptions, and such variability may preclude using gland size as an accurate predictor of disease etiology. Unfortunately, neither the weights nor sizes of the glands were reported in their study. While our data set is substantially smaller, we found that ex vivo counts of intact glands correlated with both gland weight and gland size.
Debate also exists as to whether ex vivo counts and their respective pathophysiologic groupings could be attributed to mass effect of the measured lesions rather than any distinct pathologic processes or cellular density. For instance, what does it mean when a biopsy representing a quarter of a parathyroid gland, which grossly appears normal, emits more than 20% of background radioactivity? What does it mean when an intact parathyroid adenoma, which is generally much larger than a normal gland, emits less than 20% of background radioactivity? In other words, is the 20% rule independent of weight and/or size of the parathyroid specimen? Likewise, intraoperative parathyroid specimen gamma counting, although asserted to have equivalency with an intraoperative PTH measurement by some, 12, 27 has been disputed. [28] [29] [30] [31] This is yet another reason why radioactivity and biopsy size and technique might be important variables in the assumptions of cure being used by surgeons. Finally, the reported rate of postoperative hypoparathyroidism is less than 1% in all patients undergoing parathyroidectomy for primary HPT; however, this rate increases dramatically (10%-15%) in patients with multigland hyperplasia who undergo a subtotal resection. 32, 33 Interrupting the blood supply and subsequent absence of sufficient functioning parathyroid tissue that may already be in a suppressed state from hyperparathyroidism is almost always the cause of permanent hypoparathyroidism in these patients. 25 While there are no studies with long-term data describing complication rates among patients undergoing routine biopsy of nonexcised glands, it is possible that this complication rate may arise ( Figure 4) . In addition, follow-up data are often based on the assumption that complications will be recognized, surgeons will be notified, and referral made to the original institution and not to a different center, thereby getting all relevant data captured. This is often not reality and actual complication rates are likely underappreciated in large data sets. 34 If biopsy is required, we found that pie-shaped biopsies originating from the center of the gland were associated with a lower rate of false-negative results compared with peripheral biopsies of the same size.
Limitations
There are several limitations to the present study. First, the number of patients undergoing parathyroidectomy is small. Second, because we do not biopsy normal parathyroid glands unless there is considerable suspicion that the gland is hyperfunctional, we cannot make a robust comparison of relative ex vivo counts, weight, and sizes of normal glands (or their biopsy specimens) to adenomas or hyperplastic glands. Finally, differences in timing related to sestamibi injection, gland excision, and intraoperative radioactivity measurements vary considerably by institution, and different centers do not use the same gamma probes. Future studies with larger patient populations, standardized sestamibi dosing/timing protocols, and long-term follow-up including disease persistence, recurrence, and complication rates are needed.
Conclusions
To our knowledge, this is the first study to investigate the amount of a parathyroid gland that must be resected to reliably identify a hyperfunctional lesion by the Norman 20% rule. Parathyroid biopsies accounting for less than half of a parathyroid gland are not sensitive enough to reliably rule out a hyperfunctional parathyroid gland. If performed, pie-shaped biopsies originating from the center of the gland are associated with a lower rate of false negative results compared with peripheral biopsies of the same size. However, manipulation and excision of half of 1 or more parathyroid glands for ex vivo counts may increase the patient's risk for developing hypoparathyroidism. 
